Medical Care
Global PDL1 Antibody Reagent (Immunohistochemistry) Market Research Report 2025
- May 05, 25
- ID: 228246
- Pages: 102
- Figures: 105
- Views: 8
The global market for PDL1 Antibody Reagent (Immunohistochemistry) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for PDL1 Antibody Reagent (Immunohistochemistry) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for PDL1 Antibody Reagent (Immunohistochemistry) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of PDL1 Antibody Reagent (Immunohistochemistry) include Merck, Bio-Techne, BD Biosciences, Thermo Fisher Scientific, Amoy Diagnostics, Sino Biological, ACROBiosystems, Roche Holding AG, Lifespan Biosciences, Creative Biolabs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PDL1 Antibody Reagent (Immunohistochemistry), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PDL1 Antibody Reagent (Immunohistochemistry).
The PDL1 Antibody Reagent (Immunohistochemistry) market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PDL1 Antibody Reagent (Immunohistochemistry) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PDL1 Antibody Reagent (Immunohistochemistry) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Bio-Techne
BD Biosciences
Thermo Fisher Scientific
Amoy Diagnostics
Sino Biological
ACROBiosystems
Roche Holding AG
Lifespan Biosciences
Creative Biolabs
Boster Bio
GenomeMe
Leinco Technologies
Covalab
BIOTEM
Jackson ImmunoResearch Laboratories
INNOVEX Biosciences
MEDx Translational Medicine
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Pathological Research
Drug Development
Diagnostic Test
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PDL1 Antibody Reagent (Immunohistochemistry) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PDL1 Antibody Reagent (Immunohistochemistry) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for PDL1 Antibody Reagent (Immunohistochemistry) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for PDL1 Antibody Reagent (Immunohistochemistry) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of PDL1 Antibody Reagent (Immunohistochemistry) include Merck, Bio-Techne, BD Biosciences, Thermo Fisher Scientific, Amoy Diagnostics, Sino Biological, ACROBiosystems, Roche Holding AG, Lifespan Biosciences, Creative Biolabs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PDL1 Antibody Reagent (Immunohistochemistry), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PDL1 Antibody Reagent (Immunohistochemistry).
The PDL1 Antibody Reagent (Immunohistochemistry) market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PDL1 Antibody Reagent (Immunohistochemistry) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PDL1 Antibody Reagent (Immunohistochemistry) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Bio-Techne
BD Biosciences
Thermo Fisher Scientific
Amoy Diagnostics
Sino Biological
ACROBiosystems
Roche Holding AG
Lifespan Biosciences
Creative Biolabs
Boster Bio
GenomeMe
Leinco Technologies
Covalab
BIOTEM
Jackson ImmunoResearch Laboratories
INNOVEX Biosciences
MEDx Translational Medicine
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Pathological Research
Drug Development
Diagnostic Test
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PDL1 Antibody Reagent (Immunohistochemistry) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PDL1 Antibody Reagent (Immunohistochemistry) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 PDL1 Antibody Reagent (Immunohistochemistry) Market Overview
1.1 Product Definition
1.2 PDL1 Antibody Reagent (Immunohistochemistry) by Type
1.2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 PDL1 Antibody Reagent (Immunohistochemistry) by Application
1.3.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value by Application (2024 VS 2031)
1.3.2 Pathological Research
1.3.3 Drug Development
1.3.4 Diagnostic Test
1.4 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size Estimates and Forecasts
1.4.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue 2020-2031
1.4.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales 2020-2031
1.4.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 PDL1 Antibody Reagent (Immunohistochemistry) Market Competition by Manufacturers
2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Manufacturers (2020-2025)
2.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of PDL1 Antibody Reagent (Immunohistochemistry), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Product Type & Application
2.7 Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Date of Enter into This Industry
2.8 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Competitive Situation and Trends
2.8.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest PDL1 Antibody Reagent (Immunohistochemistry) Players Market Share by Revenue
2.8.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Scenario by Region
3.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region: 2020-2031
3.2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region: 2020-2025
3.2.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region: 2026-2031
3.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region: 2020-2031
3.3.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region: 2020-2025
3.3.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region: 2026-2031
3.4 North America PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Country
3.4.1 North America PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2031)
3.4.3 North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Country
3.5.1 Europe PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2031)
3.5.3 Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Region
3.6.1 Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2020-2031)
3.6.3 Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Country
3.7.1 Latin America PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2031)
3.7.3 Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Country
3.8.1 Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2031)
3.8.3 Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Type (2020-2031)
4.1.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Type (2020-2025)
4.1.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Type (2026-2031)
4.1.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Type (2020-2031)
4.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Type (2020-2031)
4.2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Type (2020-2025)
4.2.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Type (2026-2031)
4.2.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Type (2020-2031)
4.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Price by Type (2020-2031)
5 Segment by Application
5.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Application (2020-2031)
5.1.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Application (2020-2025)
5.1.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Application (2026-2031)
5.1.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Application (2020-2031)
5.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Application (2020-2031)
5.2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Application (2020-2025)
5.2.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Application (2026-2031)
5.2.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Application (2020-2031)
5.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Company Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Techne PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 BD Biosciences
6.3.1 BD Biosciences Company Information
6.3.2 BD Biosciences Description and Business Overview
6.3.3 BD Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.3.5 BD Biosciences Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Amoy Diagnostics
6.5.1 Amoy Diagnostics Company Information
6.5.2 Amoy Diagnostics Description and Business Overview
6.5.3 Amoy Diagnostics PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Amoy Diagnostics PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.5.5 Amoy Diagnostics Recent Developments/Updates
6.6 Sino Biological
6.6.1 Sino Biological Company Information
6.6.2 Sino Biological Description and Business Overview
6.6.3 Sino Biological PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sino Biological PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.6.5 Sino Biological Recent Developments/Updates
6.7 ACROBiosystems
6.7.1 ACROBiosystems Company Information
6.7.2 ACROBiosystems Description and Business Overview
6.7.3 ACROBiosystems PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ACROBiosystems PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.7.5 ACROBiosystems Recent Developments/Updates
6.8 Roche Holding AG
6.8.1 Roche Holding AG Company Information
6.8.2 Roche Holding AG Description and Business Overview
6.8.3 Roche Holding AG PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Roche Holding AG PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.8.5 Roche Holding AG Recent Developments/Updates
6.9 Lifespan Biosciences
6.9.1 Lifespan Biosciences Company Information
6.9.2 Lifespan Biosciences Description and Business Overview
6.9.3 Lifespan Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lifespan Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.9.5 Lifespan Biosciences Recent Developments/Updates
6.10 Creative Biolabs
6.10.1 Creative Biolabs Company Information
6.10.2 Creative Biolabs Description and Business Overview
6.10.3 Creative Biolabs PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Creative Biolabs PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.10.5 Creative Biolabs Recent Developments/Updates
6.11 Boster Bio
6.11.1 Boster Bio Company Information
6.11.2 Boster Bio Description and Business Overview
6.11.3 Boster Bio PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Boster Bio PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.11.5 Boster Bio Recent Developments/Updates
6.12 GenomeMe
6.12.1 GenomeMe Company Information
6.12.2 GenomeMe Description and Business Overview
6.12.3 GenomeMe PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GenomeMe PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.12.5 GenomeMe Recent Developments/Updates
6.13 Leinco Technologies
6.13.1 Leinco Technologies Company Information
6.13.2 Leinco Technologies Description and Business Overview
6.13.3 Leinco Technologies PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Leinco Technologies PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.13.5 Leinco Technologies Recent Developments/Updates
6.14 Covalab
6.14.1 Covalab Company Information
6.14.2 Covalab Description and Business Overview
6.14.3 Covalab PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Covalab PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.14.5 Covalab Recent Developments/Updates
6.15 BIOTEM
6.15.1 BIOTEM Company Information
6.15.2 BIOTEM Description and Business Overview
6.15.3 BIOTEM PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 BIOTEM PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.15.5 BIOTEM Recent Developments/Updates
6.16 Jackson ImmunoResearch Laboratories
6.16.1 Jackson ImmunoResearch Laboratories Company Information
6.16.2 Jackson ImmunoResearch Laboratories Description and Business Overview
6.16.3 Jackson ImmunoResearch Laboratories PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Jackson ImmunoResearch Laboratories PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.16.5 Jackson ImmunoResearch Laboratories Recent Developments/Updates
6.17 INNOVEX Biosciences
6.17.1 INNOVEX Biosciences Company Information
6.17.2 INNOVEX Biosciences Description and Business Overview
6.17.3 INNOVEX Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 INNOVEX Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.17.5 INNOVEX Biosciences Recent Developments/Updates
6.18 MEDx Translational Medicine
6.18.1 MEDx Translational Medicine Company Information
6.18.2 MEDx Translational Medicine Description and Business Overview
6.18.3 MEDx Translational Medicine PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.18.4 MEDx Translational Medicine PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.18.5 MEDx Translational Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PDL1 Antibody Reagent (Immunohistochemistry) Industry Chain Analysis
7.2 PDL1 Antibody Reagent (Immunohistochemistry) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PDL1 Antibody Reagent (Immunohistochemistry) Production Mode & Process Analysis
7.4 PDL1 Antibody Reagent (Immunohistochemistry) Sales and Marketing
7.4.1 PDL1 Antibody Reagent (Immunohistochemistry) Sales Channels
7.4.2 PDL1 Antibody Reagent (Immunohistochemistry) Distributors
7.5 PDL1 Antibody Reagent (Immunohistochemistry) Customer Analysis
8 PDL1 Antibody Reagent (Immunohistochemistry) Market Dynamics
8.1 PDL1 Antibody Reagent (Immunohistochemistry) Industry Trends
8.2 PDL1 Antibody Reagent (Immunohistochemistry) Market Drivers
8.3 PDL1 Antibody Reagent (Immunohistochemistry) Market Challenges
8.4 PDL1 Antibody Reagent (Immunohistochemistry) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 PDL1 Antibody Reagent (Immunohistochemistry) by Type
1.2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 PDL1 Antibody Reagent (Immunohistochemistry) by Application
1.3.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value by Application (2024 VS 2031)
1.3.2 Pathological Research
1.3.3 Drug Development
1.3.4 Diagnostic Test
1.4 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size Estimates and Forecasts
1.4.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue 2020-2031
1.4.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales 2020-2031
1.4.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 PDL1 Antibody Reagent (Immunohistochemistry) Market Competition by Manufacturers
2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Manufacturers (2020-2025)
2.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of PDL1 Antibody Reagent (Immunohistochemistry), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Product Type & Application
2.7 Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Date of Enter into This Industry
2.8 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Competitive Situation and Trends
2.8.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest PDL1 Antibody Reagent (Immunohistochemistry) Players Market Share by Revenue
2.8.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Scenario by Region
3.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region: 2020-2031
3.2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region: 2020-2025
3.2.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region: 2026-2031
3.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region: 2020-2031
3.3.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region: 2020-2025
3.3.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region: 2026-2031
3.4 North America PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Country
3.4.1 North America PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2031)
3.4.3 North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Country
3.5.1 Europe PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2031)
3.5.3 Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Region
3.6.1 Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2020-2031)
3.6.3 Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Country
3.7.1 Latin America PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2031)
3.7.3 Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Market Facts & Figures by Country
3.8.1 Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2031)
3.8.3 Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Type (2020-2031)
4.1.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Type (2020-2025)
4.1.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Type (2026-2031)
4.1.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Type (2020-2031)
4.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Type (2020-2031)
4.2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Type (2020-2025)
4.2.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Type (2026-2031)
4.2.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Type (2020-2031)
4.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Price by Type (2020-2031)
5 Segment by Application
5.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Application (2020-2031)
5.1.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Application (2020-2025)
5.1.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Application (2026-2031)
5.1.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Application (2020-2031)
5.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Application (2020-2031)
5.2.1 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Application (2020-2025)
5.2.2 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Application (2026-2031)
5.2.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Application (2020-2031)
5.3 Global PDL1 Antibody Reagent (Immunohistochemistry) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Company Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Techne PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 BD Biosciences
6.3.1 BD Biosciences Company Information
6.3.2 BD Biosciences Description and Business Overview
6.3.3 BD Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.3.5 BD Biosciences Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Amoy Diagnostics
6.5.1 Amoy Diagnostics Company Information
6.5.2 Amoy Diagnostics Description and Business Overview
6.5.3 Amoy Diagnostics PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Amoy Diagnostics PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.5.5 Amoy Diagnostics Recent Developments/Updates
6.6 Sino Biological
6.6.1 Sino Biological Company Information
6.6.2 Sino Biological Description and Business Overview
6.6.3 Sino Biological PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sino Biological PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.6.5 Sino Biological Recent Developments/Updates
6.7 ACROBiosystems
6.7.1 ACROBiosystems Company Information
6.7.2 ACROBiosystems Description and Business Overview
6.7.3 ACROBiosystems PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ACROBiosystems PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.7.5 ACROBiosystems Recent Developments/Updates
6.8 Roche Holding AG
6.8.1 Roche Holding AG Company Information
6.8.2 Roche Holding AG Description and Business Overview
6.8.3 Roche Holding AG PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Roche Holding AG PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.8.5 Roche Holding AG Recent Developments/Updates
6.9 Lifespan Biosciences
6.9.1 Lifespan Biosciences Company Information
6.9.2 Lifespan Biosciences Description and Business Overview
6.9.3 Lifespan Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lifespan Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.9.5 Lifespan Biosciences Recent Developments/Updates
6.10 Creative Biolabs
6.10.1 Creative Biolabs Company Information
6.10.2 Creative Biolabs Description and Business Overview
6.10.3 Creative Biolabs PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Creative Biolabs PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.10.5 Creative Biolabs Recent Developments/Updates
6.11 Boster Bio
6.11.1 Boster Bio Company Information
6.11.2 Boster Bio Description and Business Overview
6.11.3 Boster Bio PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Boster Bio PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.11.5 Boster Bio Recent Developments/Updates
6.12 GenomeMe
6.12.1 GenomeMe Company Information
6.12.2 GenomeMe Description and Business Overview
6.12.3 GenomeMe PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GenomeMe PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.12.5 GenomeMe Recent Developments/Updates
6.13 Leinco Technologies
6.13.1 Leinco Technologies Company Information
6.13.2 Leinco Technologies Description and Business Overview
6.13.3 Leinco Technologies PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Leinco Technologies PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.13.5 Leinco Technologies Recent Developments/Updates
6.14 Covalab
6.14.1 Covalab Company Information
6.14.2 Covalab Description and Business Overview
6.14.3 Covalab PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Covalab PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.14.5 Covalab Recent Developments/Updates
6.15 BIOTEM
6.15.1 BIOTEM Company Information
6.15.2 BIOTEM Description and Business Overview
6.15.3 BIOTEM PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 BIOTEM PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.15.5 BIOTEM Recent Developments/Updates
6.16 Jackson ImmunoResearch Laboratories
6.16.1 Jackson ImmunoResearch Laboratories Company Information
6.16.2 Jackson ImmunoResearch Laboratories Description and Business Overview
6.16.3 Jackson ImmunoResearch Laboratories PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Jackson ImmunoResearch Laboratories PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.16.5 Jackson ImmunoResearch Laboratories Recent Developments/Updates
6.17 INNOVEX Biosciences
6.17.1 INNOVEX Biosciences Company Information
6.17.2 INNOVEX Biosciences Description and Business Overview
6.17.3 INNOVEX Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 INNOVEX Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.17.5 INNOVEX Biosciences Recent Developments/Updates
6.18 MEDx Translational Medicine
6.18.1 MEDx Translational Medicine Company Information
6.18.2 MEDx Translational Medicine Description and Business Overview
6.18.3 MEDx Translational Medicine PDL1 Antibody Reagent (Immunohistochemistry) Sales, Revenue and Gross Margin (2020-2025)
6.18.4 MEDx Translational Medicine PDL1 Antibody Reagent (Immunohistochemistry) Product Portfolio
6.18.5 MEDx Translational Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PDL1 Antibody Reagent (Immunohistochemistry) Industry Chain Analysis
7.2 PDL1 Antibody Reagent (Immunohistochemistry) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PDL1 Antibody Reagent (Immunohistochemistry) Production Mode & Process Analysis
7.4 PDL1 Antibody Reagent (Immunohistochemistry) Sales and Marketing
7.4.1 PDL1 Antibody Reagent (Immunohistochemistry) Sales Channels
7.4.2 PDL1 Antibody Reagent (Immunohistochemistry) Distributors
7.5 PDL1 Antibody Reagent (Immunohistochemistry) Customer Analysis
8 PDL1 Antibody Reagent (Immunohistochemistry) Market Dynamics
8.1 PDL1 Antibody Reagent (Immunohistochemistry) Industry Trends
8.2 PDL1 Antibody Reagent (Immunohistochemistry) Market Drivers
8.3 PDL1 Antibody Reagent (Immunohistochemistry) Market Challenges
8.4 PDL1 Antibody Reagent (Immunohistochemistry) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Competitive Situation by Manufacturers in 2024
Table 4. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) of Key Manufacturers (2020-2025)
Table 5. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market PDL1 Antibody Reagent (Immunohistochemistry) Average Price (US$/mg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of PDL1 Antibody Reagent (Immunohistochemistry), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Product Type & Application
Table 12. Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PDL1 Antibody Reagent (Immunohistochemistry) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PDL1 Antibody Reagent (Immunohistochemistry) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2020-2025) & (kg)
Table 18. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Region (2020-2025)
Table 19. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2026-2031) & (kg)
Table 20. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Region (2026-2031)
Table 21. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Region (2020-2025)
Table 23. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Region (2026-2031)
Table 25. North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2025) & (kg)
Table 27. North America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2026-2031) & (kg)
Table 28. North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2025) & (kg)
Table 32. Europe PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2026-2031) & (kg)
Table 33. Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2020-2025) & (kg)
Table 37. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2026-2031) & (kg)
Table 38. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2025) & (kg)
Table 42. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2026-2031) & (kg)
Table 43. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2025) & (kg)
Table 47. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2026-2031) & (kg)
Table 48. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) by Type (2020-2025)
Table 51. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) by Type (2026-2031)
Table 52. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Type (2020-2025)
Table 53. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Type (2026-2031)
Table 54. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Type (2020-2025)
Table 57. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Type (2026-2031)
Table 58. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Type (2020-2025)
Table 59. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Type (2026-2031)
Table 60. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) by Application (2020-2025)
Table 61. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) by Application (2026-2031)
Table 62. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Application (2020-2025)
Table 63. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Application (2026-2031)
Table 64. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Application (2020-2025)
Table 67. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Application (2026-2031)
Table 68. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Application (2020-2025)
Table 69. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 73. Merck PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 74. Merck Recent Developments/Updates
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 78. Bio-Techne PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 79. Bio-Techne Recent Developments/Updates
Table 80. BD Biosciences Company Information
Table 81. BD Biosciences Description and Business Overview
Table 82. BD Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 83. BD Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 84. BD Biosciences Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Amoy Diagnostics Company Information
Table 91. Amoy Diagnostics Description and Business Overview
Table 92. Amoy Diagnostics PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 93. Amoy Diagnostics PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 94. Amoy Diagnostics Recent Developments/Updates
Table 95. Sino Biological Company Information
Table 96. Sino Biological Description and Business Overview
Table 97. Sino Biological PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 98. Sino Biological PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 99. Sino Biological Recent Developments/Updates
Table 100. ACROBiosystems Company Information
Table 101. ACROBiosystems Description and Business Overview
Table 102. ACROBiosystems PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 103. ACROBiosystems PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 104. ACROBiosystems Recent Developments/Updates
Table 105. Roche Holding AG Company Information
Table 106. Roche Holding AG Description and Business Overview
Table 107. Roche Holding AG PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 108. Roche Holding AG PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 109. Roche Holding AG Recent Developments/Updates
Table 110. Lifespan Biosciences Company Information
Table 111. Lifespan Biosciences Description and Business Overview
Table 112. Lifespan Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 113. Lifespan Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 114. Lifespan Biosciences Recent Developments/Updates
Table 115. Creative Biolabs Company Information
Table 116. Creative Biolabs Description and Business Overview
Table 117. Creative Biolabs PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 118. Creative Biolabs PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 119. Creative Biolabs Recent Developments/Updates
Table 120. Boster Bio Company Information
Table 121. Boster Bio Description and Business Overview
Table 122. Boster Bio PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 123. Boster Bio PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 124. Boster Bio Recent Developments/Updates
Table 125. GenomeMe Company Information
Table 126. GenomeMe Description and Business Overview
Table 127. GenomeMe PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 128. GenomeMe PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 129. GenomeMe Recent Developments/Updates
Table 130. Leinco Technologies Company Information
Table 131. Leinco Technologies Description and Business Overview
Table 132. Leinco Technologies PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 133. Leinco Technologies PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 134. Leinco Technologies Recent Developments/Updates
Table 135. Covalab Company Information
Table 136. Covalab Description and Business Overview
Table 137. Covalab PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 138. Covalab PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 139. Covalab Recent Developments/Updates
Table 140. BIOTEM Company Information
Table 141. BIOTEM Description and Business Overview
Table 142. BIOTEM PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 143. BIOTEM PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 144. BIOTEM Recent Developments/Updates
Table 145. Jackson ImmunoResearch Laboratories Company Information
Table 146. Jackson ImmunoResearch Laboratories Description and Business Overview
Table 147. Jackson ImmunoResearch Laboratories PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 148. Jackson ImmunoResearch Laboratories PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 149. Jackson ImmunoResearch Laboratories Recent Developments/Updates
Table 150. INNOVEX Biosciences Company Information
Table 151. INNOVEX Biosciences Description and Business Overview
Table 152. INNOVEX Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 153. INNOVEX Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 154. INNOVEX Biosciences Recent Developments/Updates
Table 155. MEDx Translational Medicine Company Information
Table 156. MEDx Translational Medicine Description and Business Overview
Table 157. MEDx Translational Medicine PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 158. MEDx Translational Medicine PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 159. MEDx Translational Medicine Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. PDL1 Antibody Reagent (Immunohistochemistry) Distributors List
Table 163. PDL1 Antibody Reagent (Immunohistochemistry) Customers List
Table 164. PDL1 Antibody Reagent (Immunohistochemistry) Market Trends
Table 165. PDL1 Antibody Reagent (Immunohistochemistry) Market Drivers
Table 166. PDL1 Antibody Reagent (Immunohistochemistry) Market Challenges
Table 167. PDL1 Antibody Reagent (Immunohistochemistry) Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of PDL1 Antibody Reagent (Immunohistochemistry)
Figure 2. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Share by Application: 2024 & 2031
Figure 8. Pathological Research
Figure 9. Drug Development
Figure 10. Diagnostic Test
Figure 11. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size (2020-2031) & (US$ Million)
Figure 13. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (2020-2031) & (kg)
Figure 14. Global PDL1 Antibody Reagent (Immunohistochemistry) Average Price (US$/mg) & (2020-2031)
Figure 15. PDL1 Antibody Reagent (Immunohistochemistry) Report Years Considered
Figure 16. PDL1 Antibody Reagent (Immunohistochemistry) Sales Share by Manufacturers in 2024
Figure 17. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest PDL1 Antibody Reagent (Immunohistochemistry) Players: Market Share by Revenue in PDL1 Antibody Reagent (Immunohistochemistry) in 2024
Figure 19. PDL1 Antibody Reagent (Immunohistochemistry) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Country (2020-2031)
Figure 22. North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Country (2020-2031)
Figure 23. United States PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Country (2020-2031)
Figure 26. Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Country (2020-2031)
Figure 27. Germany PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Region (2020-2031)
Figure 34. China PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Country (2020-2031)
Figure 42. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Country (2020-2031)
Figure 43. Mexico PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Country (2020-2031)
Figure 48. Turkey PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of PDL1 Antibody Reagent (Immunohistochemistry) by Type (2020-2031)
Figure 52. Global Revenue Market Share of PDL1 Antibody Reagent (Immunohistochemistry) by Type (2020-2031)
Figure 53. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Type (2020-2031)
Figure 54. Global Sales Market Share of PDL1 Antibody Reagent (Immunohistochemistry) by Application (2020-2031)
Figure 55. Global Revenue Market Share of PDL1 Antibody Reagent (Immunohistochemistry) by Application (2020-2031)
Figure 56. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Application (2020-2031)
Figure 57. PDL1 Antibody Reagent (Immunohistochemistry) Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Competitive Situation by Manufacturers in 2024
Table 4. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) of Key Manufacturers (2020-2025)
Table 5. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market PDL1 Antibody Reagent (Immunohistochemistry) Average Price (US$/mg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of PDL1 Antibody Reagent (Immunohistochemistry), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Product Type & Application
Table 12. Global Key Manufacturers of PDL1 Antibody Reagent (Immunohistochemistry), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PDL1 Antibody Reagent (Immunohistochemistry) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PDL1 Antibody Reagent (Immunohistochemistry) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2020-2025) & (kg)
Table 18. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Region (2020-2025)
Table 19. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2026-2031) & (kg)
Table 20. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Region (2026-2031)
Table 21. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Region (2020-2025)
Table 23. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Region (2026-2031)
Table 25. North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2025) & (kg)
Table 27. North America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2026-2031) & (kg)
Table 28. North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2025) & (kg)
Table 32. Europe PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2026-2031) & (kg)
Table 33. Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2020-2025) & (kg)
Table 37. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Sales by Region (2026-2031) & (kg)
Table 38. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2025) & (kg)
Table 42. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2026-2031) & (kg)
Table 43. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2020-2025) & (kg)
Table 47. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Sales by Country (2026-2031) & (kg)
Table 48. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) by Type (2020-2025)
Table 51. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) by Type (2026-2031)
Table 52. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Type (2020-2025)
Table 53. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Type (2026-2031)
Table 54. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Type (2020-2025)
Table 57. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Type (2026-2031)
Table 58. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Type (2020-2025)
Table 59. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Type (2026-2031)
Table 60. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) by Application (2020-2025)
Table 61. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg) by Application (2026-2031)
Table 62. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Application (2020-2025)
Table 63. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Application (2026-2031)
Table 64. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Application (2020-2025)
Table 67. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Application (2026-2031)
Table 68. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Application (2020-2025)
Table 69. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 73. Merck PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 74. Merck Recent Developments/Updates
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 78. Bio-Techne PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 79. Bio-Techne Recent Developments/Updates
Table 80. BD Biosciences Company Information
Table 81. BD Biosciences Description and Business Overview
Table 82. BD Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 83. BD Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 84. BD Biosciences Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Amoy Diagnostics Company Information
Table 91. Amoy Diagnostics Description and Business Overview
Table 92. Amoy Diagnostics PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 93. Amoy Diagnostics PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 94. Amoy Diagnostics Recent Developments/Updates
Table 95. Sino Biological Company Information
Table 96. Sino Biological Description and Business Overview
Table 97. Sino Biological PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 98. Sino Biological PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 99. Sino Biological Recent Developments/Updates
Table 100. ACROBiosystems Company Information
Table 101. ACROBiosystems Description and Business Overview
Table 102. ACROBiosystems PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 103. ACROBiosystems PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 104. ACROBiosystems Recent Developments/Updates
Table 105. Roche Holding AG Company Information
Table 106. Roche Holding AG Description and Business Overview
Table 107. Roche Holding AG PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 108. Roche Holding AG PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 109. Roche Holding AG Recent Developments/Updates
Table 110. Lifespan Biosciences Company Information
Table 111. Lifespan Biosciences Description and Business Overview
Table 112. Lifespan Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 113. Lifespan Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 114. Lifespan Biosciences Recent Developments/Updates
Table 115. Creative Biolabs Company Information
Table 116. Creative Biolabs Description and Business Overview
Table 117. Creative Biolabs PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 118. Creative Biolabs PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 119. Creative Biolabs Recent Developments/Updates
Table 120. Boster Bio Company Information
Table 121. Boster Bio Description and Business Overview
Table 122. Boster Bio PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 123. Boster Bio PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 124. Boster Bio Recent Developments/Updates
Table 125. GenomeMe Company Information
Table 126. GenomeMe Description and Business Overview
Table 127. GenomeMe PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 128. GenomeMe PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 129. GenomeMe Recent Developments/Updates
Table 130. Leinco Technologies Company Information
Table 131. Leinco Technologies Description and Business Overview
Table 132. Leinco Technologies PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 133. Leinco Technologies PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 134. Leinco Technologies Recent Developments/Updates
Table 135. Covalab Company Information
Table 136. Covalab Description and Business Overview
Table 137. Covalab PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 138. Covalab PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 139. Covalab Recent Developments/Updates
Table 140. BIOTEM Company Information
Table 141. BIOTEM Description and Business Overview
Table 142. BIOTEM PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 143. BIOTEM PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 144. BIOTEM Recent Developments/Updates
Table 145. Jackson ImmunoResearch Laboratories Company Information
Table 146. Jackson ImmunoResearch Laboratories Description and Business Overview
Table 147. Jackson ImmunoResearch Laboratories PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 148. Jackson ImmunoResearch Laboratories PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 149. Jackson ImmunoResearch Laboratories Recent Developments/Updates
Table 150. INNOVEX Biosciences Company Information
Table 151. INNOVEX Biosciences Description and Business Overview
Table 152. INNOVEX Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 153. INNOVEX Biosciences PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 154. INNOVEX Biosciences Recent Developments/Updates
Table 155. MEDx Translational Medicine Company Information
Table 156. MEDx Translational Medicine Description and Business Overview
Table 157. MEDx Translational Medicine PDL1 Antibody Reagent (Immunohistochemistry) Sales (kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
Table 158. MEDx Translational Medicine PDL1 Antibody Reagent (Immunohistochemistry) Product
Table 159. MEDx Translational Medicine Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. PDL1 Antibody Reagent (Immunohistochemistry) Distributors List
Table 163. PDL1 Antibody Reagent (Immunohistochemistry) Customers List
Table 164. PDL1 Antibody Reagent (Immunohistochemistry) Market Trends
Table 165. PDL1 Antibody Reagent (Immunohistochemistry) Market Drivers
Table 166. PDL1 Antibody Reagent (Immunohistochemistry) Market Challenges
Table 167. PDL1 Antibody Reagent (Immunohistochemistry) Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of PDL1 Antibody Reagent (Immunohistochemistry)
Figure 2. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Share by Application: 2024 & 2031
Figure 8. Pathological Research
Figure 9. Drug Development
Figure 10. Diagnostic Test
Figure 11. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size (2020-2031) & (US$ Million)
Figure 13. Global PDL1 Antibody Reagent (Immunohistochemistry) Sales (2020-2031) & (kg)
Figure 14. Global PDL1 Antibody Reagent (Immunohistochemistry) Average Price (US$/mg) & (2020-2031)
Figure 15. PDL1 Antibody Reagent (Immunohistochemistry) Report Years Considered
Figure 16. PDL1 Antibody Reagent (Immunohistochemistry) Sales Share by Manufacturers in 2024
Figure 17. Global PDL1 Antibody Reagent (Immunohistochemistry) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest PDL1 Antibody Reagent (Immunohistochemistry) Players: Market Share by Revenue in PDL1 Antibody Reagent (Immunohistochemistry) in 2024
Figure 19. PDL1 Antibody Reagent (Immunohistochemistry) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global PDL1 Antibody Reagent (Immunohistochemistry) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Country (2020-2031)
Figure 22. North America PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Country (2020-2031)
Figure 23. United States PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Country (2020-2031)
Figure 26. Europe PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Country (2020-2031)
Figure 27. Germany PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Region (2020-2031)
Figure 34. China PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Country (2020-2031)
Figure 42. Latin America PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Country (2020-2031)
Figure 43. Mexico PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa PDL1 Antibody Reagent (Immunohistochemistry) Revenue Market Share by Country (2020-2031)
Figure 48. Turkey PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE PDL1 Antibody Reagent (Immunohistochemistry) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of PDL1 Antibody Reagent (Immunohistochemistry) by Type (2020-2031)
Figure 52. Global Revenue Market Share of PDL1 Antibody Reagent (Immunohistochemistry) by Type (2020-2031)
Figure 53. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Type (2020-2031)
Figure 54. Global Sales Market Share of PDL1 Antibody Reagent (Immunohistochemistry) by Application (2020-2031)
Figure 55. Global Revenue Market Share of PDL1 Antibody Reagent (Immunohistochemistry) by Application (2020-2031)
Figure 56. Global PDL1 Antibody Reagent (Immunohistochemistry) Price (US$/mg) by Application (2020-2031)
Figure 57. PDL1 Antibody Reagent (Immunohistochemistry) Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Double-handle Kitchen Mixer Tap Market Research Report 2025
Jul 24, 25
Global Kitchen Mixer Tap Market Research Report 2025
Jul 24, 25
Global Kitchen Collection Market Research Report 2025
Jul 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232